nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—Malabsorption—Octreotide—thymus cancer	0.116	0.126	CcSEcCtD
Olmesartan—Diabetic—Octreotide—thymus cancer	0.0503	0.055	CcSEcCtD
Olmesartan—Appetite absent—Octreotide—thymus cancer	0.0338	0.0369	CcSEcCtD
Olmesartan—Creatine phosphokinase increased—Octreotide—thymus cancer	0.0319	0.0349	CcSEcCtD
Olmesartan—Transaminases increased—Octreotide—thymus cancer	0.0276	0.0302	CcSEcCtD
Olmesartan—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0244	0.0267	CcSEcCtD
Olmesartan—Influenza-like symptoms—Octreotide—thymus cancer	0.0235	0.0257	CcSEcCtD
Olmesartan—Jaundice cholestatic—Octreotide—thymus cancer	0.0191	0.0209	CcSEcCtD
Olmesartan—Viral infection—Octreotide—thymus cancer	0.0186	0.0203	CcSEcCtD
Olmesartan—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0185	0.0202	CcSEcCtD
Olmesartan—Hyperkalaemia—Octreotide—thymus cancer	0.0165	0.018	CcSEcCtD
Olmesartan—Influenza like illness—Octreotide—thymus cancer	0.0163	0.0178	CcSEcCtD
Olmesartan—Sleep disorder—Octreotide—thymus cancer	0.0141	0.0154	CcSEcCtD
Olmesartan—Diabetes mellitus—Octreotide—thymus cancer	0.014	0.0153	CcSEcCtD
Olmesartan—Gastroenteritis—Octreotide—thymus cancer	0.0138	0.015	CcSEcCtD
Olmesartan—Injury—Octreotide—thymus cancer	0.0133	0.0145	CcSEcCtD
Olmesartan—Arthritis—Octreotide—thymus cancer	0.0125	0.0137	CcSEcCtD
Olmesartan—Pain in extremity—Octreotide—thymus cancer	0.0122	0.0133	CcSEcCtD
Olmesartan—Nasopharyngitis—Octreotide—thymus cancer	0.0109	0.0119	CcSEcCtD
Olmesartan—AGTR1—neck—thymus cancer	0.0108	0.128	CbGeAlD
Olmesartan—Influenza—Octreotide—thymus cancer	0.0105	0.0115	CcSEcCtD
Olmesartan—Pancreatitis—Octreotide—thymus cancer	0.0103	0.0113	CcSEcCtD
Olmesartan—Bronchitis—Octreotide—thymus cancer	0.0101	0.0111	CcSEcCtD
Olmesartan—SLCO1B3—pituitary gland—thymus cancer	0.00985	0.116	CbGeAlD
Olmesartan—Upper respiratory tract infection—Octreotide—thymus cancer	0.00979	0.0107	CcSEcCtD
Olmesartan—Hyperglycaemia—Octreotide—thymus cancer	0.0095	0.0104	CcSEcCtD
Olmesartan—Pneumonia—Octreotide—thymus cancer	0.00945	0.0103	CcSEcCtD
Olmesartan—Jaundice—Octreotide—thymus cancer	0.00916	0.01	CcSEcCtD
Olmesartan—Urinary tract infection—Octreotide—thymus cancer	0.00913	0.00998	CcSEcCtD
Olmesartan—Haematuria—Octreotide—thymus cancer	0.00896	0.00978	CcSEcCtD
Olmesartan—Sinusitis—Octreotide—thymus cancer	0.00881	0.00963	CcSEcCtD
Olmesartan—Rhinitis—Octreotide—thymus cancer	0.00845	0.00924	CcSEcCtD
Olmesartan—Pharyngitis—Octreotide—thymus cancer	0.00837	0.00914	CcSEcCtD
Olmesartan—Oedema peripheral—Octreotide—thymus cancer	0.00831	0.00908	CcSEcCtD
Olmesartan—AGTR1—hematopoietic system—thymus cancer	0.00805	0.0952	CbGeAlD
Olmesartan—SLCO1B3—lung—thymus cancer	0.00771	0.0912	CbGeAlD
Olmesartan—SLCO1B1—hematopoietic system—thymus cancer	0.00768	0.0908	CbGeAlD
Olmesartan—Arrhythmia—Octreotide—thymus cancer	0.00753	0.00823	CcSEcCtD
Olmesartan—Alopecia—Octreotide—thymus cancer	0.00745	0.00814	CcSEcCtD
Olmesartan—Mental disorder—Octreotide—thymus cancer	0.00739	0.00807	CcSEcCtD
Olmesartan—AGTR1—epithelium—thymus cancer	0.00736	0.087	CbGeAlD
Olmesartan—Malnutrition—Octreotide—thymus cancer	0.00734	0.00802	CcSEcCtD
Olmesartan—Back pain—Octreotide—thymus cancer	0.0071	0.00776	CcSEcCtD
Olmesartan—Muscle spasms—Octreotide—thymus cancer	0.00706	0.00771	CcSEcCtD
Olmesartan—Vision blurred—Octreotide—thymus cancer	0.00692	0.00756	CcSEcCtD
Olmesartan—Ill-defined disorder—Octreotide—thymus cancer	0.00681	0.00744	CcSEcCtD
Olmesartan—Anaemia—Octreotide—thymus cancer	0.00679	0.00741	CcSEcCtD
Olmesartan—Agitation—Octreotide—thymus cancer	0.00675	0.00737	CcSEcCtD
Olmesartan—Malaise—Octreotide—thymus cancer	0.00662	0.00723	CcSEcCtD
Olmesartan—Vertigo—Octreotide—thymus cancer	0.0066	0.00721	CcSEcCtD
Olmesartan—Syncope—Octreotide—thymus cancer	0.00658	0.00719	CcSEcCtD
Olmesartan—Palpitations—Octreotide—thymus cancer	0.00649	0.00709	CcSEcCtD
Olmesartan—Loss of consciousness—Octreotide—thymus cancer	0.00645	0.00705	CcSEcCtD
Olmesartan—Cough—Octreotide—thymus cancer	0.00641	0.007	CcSEcCtD
Olmesartan—Chest pain—Octreotide—thymus cancer	0.00625	0.00683	CcSEcCtD
Olmesartan—Arthralgia—Octreotide—thymus cancer	0.00625	0.00683	CcSEcCtD
Olmesartan—Myalgia—Octreotide—thymus cancer	0.00625	0.00683	CcSEcCtD
Olmesartan—Anxiety—Octreotide—thymus cancer	0.00623	0.0068	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00621	0.00678	CcSEcCtD
Olmesartan—Discomfort—Octreotide—thymus cancer	0.00618	0.00675	CcSEcCtD
Olmesartan—AGTR1—cardiac atrium—thymus cancer	0.00611	0.0723	CbGeAlD
Olmesartan—Anaphylactic shock—Octreotide—thymus cancer	0.00599	0.00655	CcSEcCtD
Olmesartan—Oedema—Octreotide—thymus cancer	0.00599	0.00655	CcSEcCtD
Olmesartan—AGTR1—pituitary gland—thymus cancer	0.00597	0.0706	CbGeAlD
Olmesartan—Infection—Octreotide—thymus cancer	0.00595	0.0065	CcSEcCtD
Olmesartan—Shock—Octreotide—thymus cancer	0.00589	0.00644	CcSEcCtD
Olmesartan—Nervous system disorder—Octreotide—thymus cancer	0.00588	0.00642	CcSEcCtD
Olmesartan—Thrombocytopenia—Octreotide—thymus cancer	0.00587	0.00641	CcSEcCtD
Olmesartan—Tachycardia—Octreotide—thymus cancer	0.00585	0.00639	CcSEcCtD
Olmesartan—Skin disorder—Octreotide—thymus cancer	0.00582	0.00636	CcSEcCtD
Olmesartan—Hyperhidrosis—Octreotide—thymus cancer	0.00579	0.00633	CcSEcCtD
Olmesartan—Anorexia—Octreotide—thymus cancer	0.00571	0.00624	CcSEcCtD
Olmesartan—AGTR1—lymphoid tissue—thymus cancer	0.00567	0.067	CbGeAlD
Olmesartan—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00546	0.00596	CcSEcCtD
Olmesartan—Insomnia—Octreotide—thymus cancer	0.00542	0.00592	CcSEcCtD
Olmesartan—Dyspepsia—Octreotide—thymus cancer	0.00527	0.00576	CcSEcCtD
Olmesartan—Decreased appetite—Octreotide—thymus cancer	0.00521	0.00569	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Octreotide—thymus cancer	0.00517	0.00565	CcSEcCtD
Olmesartan—Fatigue—Octreotide—thymus cancer	0.00517	0.00564	CcSEcCtD
Olmesartan—AGTR1—thyroid gland—thymus cancer	0.00515	0.0609	CbGeAlD
Olmesartan—Pain—Octreotide—thymus cancer	0.00512	0.0056	CcSEcCtD
Olmesartan—Constipation—Octreotide—thymus cancer	0.00512	0.0056	CcSEcCtD
Olmesartan—Feeling abnormal—Octreotide—thymus cancer	0.00494	0.00539	CcSEcCtD
Olmesartan—Gastrointestinal pain—Octreotide—thymus cancer	0.0049	0.00535	CcSEcCtD
Olmesartan—Urticaria—Octreotide—thymus cancer	0.00476	0.0052	CcSEcCtD
Olmesartan—Body temperature increased—Octreotide—thymus cancer	0.00474	0.00517	CcSEcCtD
Olmesartan—Abdominal pain—Octreotide—thymus cancer	0.00474	0.00517	CcSEcCtD
Olmesartan—AGTR1—lung—thymus cancer	0.00468	0.0553	CbGeAlD
Olmesartan—Asthenia—Octreotide—thymus cancer	0.0043	0.0047	CcSEcCtD
Olmesartan—Pruritus—Octreotide—thymus cancer	0.00424	0.00463	CcSEcCtD
Olmesartan—Diarrhoea—Octreotide—thymus cancer	0.0041	0.00448	CcSEcCtD
Olmesartan—Dizziness—Octreotide—thymus cancer	0.00396	0.00433	CcSEcCtD
Olmesartan—Vomiting—Octreotide—thymus cancer	0.00381	0.00416	CcSEcCtD
Olmesartan—Rash—Octreotide—thymus cancer	0.00378	0.00413	CcSEcCtD
Olmesartan—Dermatitis—Octreotide—thymus cancer	0.00377	0.00412	CcSEcCtD
Olmesartan—Headache—Octreotide—thymus cancer	0.00375	0.0041	CcSEcCtD
Olmesartan—Nausea—Octreotide—thymus cancer	0.00356	0.00389	CcSEcCtD
Olmesartan—AGTR1—lymph node—thymus cancer	0.0032	0.0378	CbGeAlD
Olmesartan—ABCC2—lymph node—thymus cancer	0.00231	0.0273	CbGeAlD
